ArticleInternational journal of cancer2019

Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels predict efficacy of bevacizumab in metastatic colorectal cancer patients.

Mitsukuni Suenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.